Aarti Pharmalabs
Ticker > Company >

Aarti Pharmalabs share price

Aarti Pharmalabs Ltd.

NSE: AARTIPHARM BSE: 543748 SECTOR: Pharmaceuticals & Drugs  78.5 K   135   41

910.00
+8.95 (0.99%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 917.5

Today's Low

₹ 901

52 Week High

₹ 971.5

52 Week Low

₹ 550.25

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 8248.35 Cr.

Enterprise Value

₹ 8639.69 Cr.

No. of Shares

9.06 Cr.

P/E

31.55

P/B

4.36

Face Value

₹ 5

Div. Yield

0.55 %

Book Value (TTM)

₹  208.89

CASH

₹ 3.52 Cr.

DEBT

₹ 394.86 Cr.

Promoter Holding

43.72 %

EPS (TTM)

₹  28.84

Sales Growth

17.92%

ROE

14.86 %

ROCE

17.61%

Profit Growth

28.26 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year17.92%
3 Year23.47%
5 Year∞%

Profit Growth

1 Year28.26%
3 Year34.1%
5 Year572.77%

ROE%

1 Year14.86%
3 Year13.6%
5 Year11.21%

ROCE %

1 Year17.61%
3 Year16.59%
5 Year13.17%

Debt/Equity

0.2143

Price to Cash Flow

24.26

Interest Cover Ratio

14.1213

CFO/PAT (5 Yr. Avg.)

0.916213033274686

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 43.72 0.01
Mar 2025 44.29 0.00
Dec 2024 44.66 0.00
Sep 2024 46.10 0.00
Jun 2024 46.46 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 34.0963737099923% for the Past 3 years.
  • The company has shown a good revenue growth of 23.4717496247696% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 14.1213.

 Limitations

  • Promoter pledging has increased from 0% to 0.01% in 1 quarter.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 393.49 377.29 470.95 529.62 375.31
Total Expenditure 309.83 292.52 355.96 386.5 280.18
Operating Profit 83.65 84.77 114.99 143.13 95.13
Other Income 2.11 2.95 11.94 -2.51 1.6
Interest 4.25 5.39 9.7 6.29 6.8
Depreciation 18.29 18.89 21.04 20.83 22.76
Exceptional Items 0 0 0 0 0
Profit Before Tax 63.23 63.43 96.18 113.5 67.17
Tax 16.08 15.6 22.66 24.66 15.95
Profit After Tax 47.14 47.84 73.52 88.85 51.22
Adjusted EPS (Rs) 5.2 5.28 8.11 9.8 5.65

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0 941.02 1511.25 1502.13 1771.35
Total Expenditure 0 761.24 1202.91 1155.97 1344.81
Operating Profit 0 179.79 308.34 346.16 426.54
Other Income 0 2.51 1.28 11.01 14.49
Interest 0 11.34 20.49 16.63 25.63
Depreciation 0 37.23 55.77 66.01 79.06
Exceptional Items 0 0 0 0 0
Profit Before Tax 0 133.73 233.36 274.52 336.34
Tax 0 27 61.63 73.87 78.99
Net Profit 0 106.73 171.73 200.65 257.35
Adjusted EPS (Rs.) -0.18 4269.05 18.95 22.14 28.39

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.25 0.25 45.31 45.31 45.32
Total Reserves -0.02 1284.03 1393.27 1576.15 1798.55
Borrowings 0 0 0 0 103.56
Other N/C liabilities 0 60.88 74.04 119.87 153.85
Current liabilities 0.02 481.67 463.75 555.58 622.33
Total Liabilities 0.25 1826.83 1976.37 2296.91 2723.61
Assets
Net Block 0 701.12 848.4 953.33 1059.32
Capital WIP 0 165.23 62.23 78.5 300.92
Intangible WIP 0 22.14 39.67 58.42 67.77
Investments 0 39.87 42.67 43.83 41.15
Loans & Advances 0 8.21 17.18 28.77 41.63
Other N/C Assets 0 0 0 0 0
Current Assets 0.25 890.27 966.22 1134.06 1212.8
Total Assets 0.25 1826.83 1976.37 2296.91 2723.61
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0 133.73 233.36 274.52 336.34
Adjustment 0 46.08 76.87 80.71 109.05
Changes in Assets & Liabilities 0 -229.65 -37.61 -124.55 -46.88
Tax Paid 0 -15 -56.73 -46.99 -58.5
Operating Cash Flow 0 -64.84 215.88 183.69 340.01
Investing Cash Flow 0 -133.54 -115.55 -184.4 -419.8
Financing Cash Flow 0 254.63 -156.53 4.4 78.63
Net Cash Flow 0 56.25 -56.2 3.7 -1.16

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 46.46 46.10 44.66 44.29 43.72
aarnav rashesh gogri 0.61 0.61 0.61 0.61 0.61
aashay rashesh gogri 0.61 0.61 0.61 0.61 0.61
aashyav business trust (a... 0.04 0.04 0.04 0.04 0.04
alchemie financial servic... 0.74 0.74 0.74 0.74 0.74
alchemie finserv pvt. ltd... 0.29 0.29 0.29 0.29 0.29
anushakti enterprise priv... 3.28 3.28 3.28 3.30 3.30
arti rajendra gogri 0.52 0.52 0.52 0.50 0.50
bhanu pradip savla 0.17 0.17 0.17 0.17 0.17
bhavna family private tru... 0.89 0.89 0.89 0.89 0.89
chandrakant vallabhaji go... 0.17 0.17 0.17 0.17 0.17
dilesh roadlines pvt ltd 0.01 0.01 0.01 0.01 0.01
dinesh devchand ghalla - - - 0.11 0.11
gogri finserv pvt. ltd. 0.37 0.37 0.37 0.37 0.37
gunavanti navin shah 0.10 0.10 0.10 0.10 0.10
heena bhatia 0.36 0.36 0.36 0.36 0.36
heena family private trus... 0.92 0.92 0.92 0.92 0.92
hetal gogri gala 2.89 2.89 2.89 2.89 2.89
hetvi rohan ghalla - - - 0.17 0.17
indira madan dedhia 0.20 0.20 0.20 0.20 0.20
jasmine family trust (rel... 0.76 0.76 0.76 0.76 0.76
jaya chandrakant gogri 2.97 2.97 3.54 3.54 3.54
jayesh shah 0.02 0.02 0.02 0.02 0.02
krisha yogesh nahar - - - 0.05 0.05
labdhi business trust (sa... 3.14 3.14 3.14 3.14 3.14
lotus family trust (gloir... 0.69 0.69 0.69 0.69 0.69
mananjay singh garewal 0.18 0.18 0.18 0.18 0.18
manisha rashesh gogri 0.61 0.61 0.61 0.61 0.61
manomaya business trust (... 1.44 1.44 1.44 1.44 1.44
mirik rajendra gogri 3.08 3.08 3.08 3.08 3.08
monisha bhatia 0.13 0.13 0.13 0.13 0.13
nehal garewal 1.24 1.24 1.24 1.24 1.24
nikhil holdings private l... 0.20 0.20 0.20 0.20 0.20
nikhil parimal desai 0.85 0.85 0.85 0.79 0.75
orchid family trust (rela... 1.82 1.64 0.86 0.75 0.56
parimal hasmukhlal desai 0.44 0.44 0.44 0.39 0.39
rajendra vallabhaji gogri... 1.57 1.57 1.57 1.57 1.57
rajendra vallabhaji gogri... - - - - 0.34
rashesh chandrakant gogri... 4.23 4.23 4.23 4.23 4.23
ratanben premji gogri 0.37 0.37 0.37 0.38 0.38
renil rajendra gogri 3.08 3.08 3.08 2.81 2.81
safechem enterprises priv... 1.61 1.61 1.61 1.61 1.61
sarla shantilal shah 2.69 2.69 2.69 2.69 2.69
shantilal tejshi shah huf... - - - - 0.31
shreya suneja 0.12 0.12 0.12 0.12 0.12
tulip family trust (gloir... 1.82 1.64 0.98 0.78 0.44
valiant organics limited 0.01 0.01 0.01 0.01 0.01
rajendra vallabhaji gogri... 0.34 0.34 0.34 0.34 -
shantilal tejshi shah (hu... 0.31 0.31 0.31 0.31 -
bhavna shah lalka 0.57 0.57 - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 53.54 53.90 55.34 55.71 56.28
investor education and pr... 0.35 - - 0.35 0.34
life insurance corporatio... 6.06 6.06 6.06 6.06 6.00
llp 0.41 0.39 - 0.30 0.15
nishant pradip shah 1.10 1.10 1.10 1.10 1.10
ntasain discovery master ... 1.89 2.58 3.37 2.21 1.88
investor education and pr... - 0.35 0.35 - -
morgan stanley investment... 1.02 1.00 1.00 - -
quant mutual fund - quant... - 3.25 3.25 - -
aditya birla sun life tru... 1.05 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q3FY24
Concall Q1FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY23
Presentation Q3FY25
Presentation Q3FY24
Presentation Q1FY24

Company News

Aarti Pharmalabs Stock Price Analysis and Quick Research Report. Is Aarti Pharmalabs an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Aarti Pharmalabs. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Aarti Pharmalabs has a PE ratio of 31.6363749835308 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Aarti Pharmalabs has ROA of 10.2519% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Aarti Pharmalabs has a Current ratio of 1.9488.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Aarti Pharmalabs has a ROE of 14.8612%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Aarti Pharmalabs has a Debt to Equity ratio of 0.2143 which means that the company has low proportion of debt in its capital.

  • Sales growth: Aarti Pharmalabs has reported revenue growth of 17.9225% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Aarti Pharmalabs for the current financial year is 24.0801008585646%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Aarti Pharmalabs is Rs 5 and the yield is 0.5469%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Aarti Pharmalabs is Rs 28.8418. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Aarti Pharmalabs in Ticker for free. Also, one can get the intrinsic value of Aarti Pharmalabs by using Valuation Calculators, which are available with a Finology ONE subscription. 

Aarti Pharmalabs FAQs

Q1. What is Aarti Pharmalabs share price today?
Ans: The current share price of Aarti Pharmalabs is Rs 912.45.

Q2. What is the market capitalisation of Aarti Pharmalabs?
Ans: Aarti Pharmalabs has a market capitalisation of Rs 8270.55848388 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Aarti Pharmalabs?
Ans: The PE ratio of Aarti Pharmalabs is 31.6363749835308 and the P/B ratio of Aarti Pharmalabs is 4.36818256891934, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Aarti Pharmalabs share?
Ans: The 52-week high share price of Aarti Pharmalabs is Rs 971, and the 52-week low share price of Aarti Pharmalabs is Rs 557.05.

Q5. Does Aarti Pharmalabs pay dividends?
Ans: Currently, Aarti Pharmalabs pays dividends. Dividend yield of Aarti Pharmalabs is around 0.5469%.

Q6. What are the face value and book value of Aarti Pharmalabs shares?
Ans: The face value of Aarti Pharmalabs shares is Rs 5, while the book value per share of Aarti Pharmalabs is around Rs 208.8855. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Aarti Pharmalabs?
Ans: Aarti Pharmalabs has a total debt of Rs 394.8551 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Aarti Pharmalabs?
Ans: The ROE of Aarti Pharmalabs is 14.8612% and ROCE of Aarti Pharmalabs is 17.6101%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Aarti Pharmalabs a good buy for the long term?
Ans: The Aarti Pharmalabs long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Aarti Pharmalabs undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Aarti Pharmalabs appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Aarti Pharmalabs’s financials?
Ans: You can review Aarti Pharmalabs’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Aarti Pharmalabs
X